Monday, 16 April 2012 09:10
‘The treatment, which uses viruses carrying human DNA to direct the body’s natural defences against cancer cells, is the first prostate cancer vaccine ever to reach late stage “phase three” trials in Europe.
No vaccines have yet been approved in Britain to treat any type of cancer, and scientists believe it could not only double the survival rate of prostate cancer sufferers but give way to a new range of similar treatments for other tumour types.’
Read more: Prostate Cancer Vaccine Contains Genetically Modified DNA
Related posts:
Lucid Awareness Gives Incredible Insight Into Human Consciousness
Gerard Baden-Clay's bid for bail on murder charge is heard in Brisbane's ...
Race row hits the Archers as show is accused of stereotyping new black character as a womaniser
Japan PM urged to be cautious about nuclear restarts
NY stage set for a second Madoff to face prison
Arctic CO2 Hitting 400ppm
Views: 0